Class I genes have split from the MHC in the tammar wallabyDeakin J.E.a · Siddle H.V.b · Cross J.G.R.a · Belov K.b · Graves J.A.M.a
aARC Centre for Kangaroo Genomics, Research School of Biological Sciences, The Australian National University, Canberra, and bCentre for Advanced Technologies in Animal Genetics and Reproduction, Faculty of Veterinary Science, University of Sydney, Sydney (Australia)
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Genes within the Major Histocompatibility Complex (MHC) are critical to the immune response and immunoregulation. Comparative studies have revealed that the MHC has undergone many changes throughout evolution yet in tetrapods the three different classes of MHC genes have maintained linkage, suggesting that there may be some functional advantage obtained by maintaining this clustering of MHC genes. Here we present data showing that class II and III genes, the antigen processing gene TAP2, and MHC framework genes are found together in the tammar wallaby on chromosome 2. Surprisingly class I loci were not found on chromosome 2 but were mapped to ten different locations spread across six chromosomes. This distribution of class I loci in the wallaby on nearly all autosomes is not a characteristic of all marsupials and may be a relatively recent phenomenon. It highlights the need for the inclusion of more than one marsupial species in comparative studies and raises questions regarding the functional significance of the clustering of MHC genes.
© 2007 S. Karger AG, Basel
- Alsop AE, Miethke P, Rofe R, Koina E, Sankovic N, et al: Characterizing the chromosomes of the Australian model marsupial Macropus eugenii (tammar wallaby). Chromosome Res 13:627–636 (2005).
- Amadou C: Evolution of the Mhc class I region: the framework hypothesis. Immunogenetics 49:362–367 (1999).
- Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, et al: Recent segmental duplications in the human genome. Science 297:1003–1007 (2002).
- Belov K, Hellman L, Cooper DW: Characterisation of echidna IgM provides insights into the time of divergence of extant mammals. Dev Comp Immunol 26:831–839 (2002).
- Belov K, Deakin JE, Papenfuss AT, Baker ML, Melman SD, et al: Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. Plos Biology 4:317–328 (2006).
- Browning TL, Belov K, Miller RD, Eldridge MD: Molecular cloning and characterization of the polymorphic MHC class II DBB from the tammar wallaby (Macropus eugenii). Immunogenetics 55:791–795 (2004).
- Cheng S, Smart M, Hanson J, David CS: Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. J Autoimmun 21:195–199 (2003).
- Cross JGR, Harrison GA, Coggill P, Sims S, Beck S, et al: Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. Cytogenet Genome Res 111:110–117 (2005).
- Dawkins R, Leelayuwat C, Gaudieri S, Tay G, Hui J, et al: Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev 167:275–304 (1999).
- Ferreri GC, Marzelli M, Rens W, O’Neill RJ: A centromere-specific retroviral element associated with breaks of synteny in macropodine marsupials. Cytogenet Genome Res 107:115–118 (2004).
- Flajnik MF, Kasahara M: Comparative genomics of the MHC: glimpses into the evolution of the adaptive immune system. Immunity 15:351–362 (2001).
- Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299 (1994).
- Harrison GA, Deane EM: cDNA sequence of the lymphotoxin beta chain from a marsupial, Macropus eugenii (Tammar wallaby). J Interferon Cytokine Res 19:1099–1102 (1999).
- Harrison GA, Deane EM: cDNA cloning of lymphotoxin alpha (LT-alpha) from a marsupial, Macropus eugenii. DNA Seq 10:399–403 (2000).
- Harrison GA, Broughton MJ, Young LJ, Cooper DW, Deane EM: Conservation of 3′ untranslated region elements in tammar wallaby (Macropus eugenii) TNF-alpha mRNA. Immunogenetics 49:464–467 (1999).
- Kelley J, Walter L, Trowsdale J: Comparative genomics of major histocompatibility complexes. Immunogenetics 56:683–695 (2005).
- Kulski JK, Gaudieri S, Inoko H, Dawkins RL: Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol 48:675–683 (1999).
- Kulski JK, Anzai T, Inoko H: ERVK9, transposons and the evolution of MHC class I duplicons within the alpha-block of the human and chimpanzee. Cytogenet Genome Res 110:181–192 (2005).
- Kuroda N, Figueroa F, O’Huigin C, Klein J: Evidence that the separation of Mhc class II from class I loci in the zebrafish, Danio rerio, occurred by translocation. Immunogenetics 54:418–430 (2002).
- Langer-Safer PR, Levine M, Ward DC: Immunological method for mapping genes on Drosophila polytene chromosomes. Proc Natl Acad Sci USA 79:4381–4385 (1982).
- Linardopoulou EV, Williams EM, Fan Y, Friedman C, Young JM, Trask BJ: Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication. Nature 437:94–100 (2005).
- Miska KB, Wright AM, Lundgren R, Sasaki-McClees R, Osterman A, et al: Analysis of a marsupial MHC region containing two recently duplicated class I loci. Mamm Genome 15:851–864 (2004).
- O’Neill RJ, O’Neill MJ, Graves JA: Undermethylation associated with retroelement activation and chromosome remodelling in an interspecific mammalian hybrid. Nature 393:68–72 (1998).
- Ohta Y, Goetz W, Hossain MZ, Nonaka M, Flajnik MF: Ancestral organization of the MHC revealed in the amphibian Xenopus. J Immunol 176:3674–3685 (2006).
- Porcelli SA, Modlin RL: The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17:297–329 (1999).
- Rens W, O’Brien PC, Fairclough H, Harman L, Graves JA, Ferguson-Smith MA: Reversal and convergence in marsupial chromosome evolution. Cytogenet Genome Res 102:282–290 (2003).
- Sankovic N, Bawden W, Martyn J, Graves JAM, Zuelke K: Construction of a marsupial bacterial artificial chromosome library from the model Australian marsupial, the tammar wallaby (Macropus eugenii). Austral J Zool 53:389–393 (2005).
- Sato A, Figueroa F, Murray BW, Malaga-Trillo E, Zaleska-Rutczynska Z, et al: Nonlinkage of major histocompatibility complex class I and class II loci in bony fishes. Immunogenetics 51:108–116 (2000).
- Siddle HV, Deakin JE, Baker ML, Miller RD, Belov K: Isolation of major histocompatibility complex Class I genes from the tammar wallaby (Macropus eugenii). Immunogenetics 58:487–493 (2006).
- Slade RW, Hale PT, Francis DI, Graves JA, Sturm RA: The marsupial MHC: the tammar wallaby, Macropus eugenii, contains an expressed DNA-like gene on chromosome 1. J Mol Evol 38:496–505 (1994).
- Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680 (1994).
- Townsend A, Bodmer H: Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601–624 (1989).
- Trowsdale J, Powis SH: The MHC: relationship between linkage and function. Curr Opin Genet Dev 2:492–497 (1992).
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.